CHM-081 (SGT-4) is a recreational designer drug which is classed as a synthetic cannabinoid. It is from the naphthoylindole family, being the 1-cyclohexylmethyl instead of 1-pentyl analogue of JWH-081, and produces cannabis-like effects. It has been identified as an ingredient in synthetic cannabis products in various countries including the USA and Australia.[1][2]
Identifiers | |
---|---|
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C27H27NO2 |
Molar mass | 397.518 g·mol−1 |
3D model (JSmol) | |
| |
|
See also
editReferences
edit- ^ Edmunds R, Locos O, Brown D, Reynolds D (2013). "Identification of the synthetic cannabinoid (1-(cyclohexylmethyl)-1H-indol-3-yl)(4-methoxynaphthalen-1-yl)methanone on plant material" (PDF). Microgram Journal. 10 (1): 3–7.
- ^ Blakey K, Boyd S, Atkinson S, Wolf J, Slottje PM, Goodchild K, McGowan J (March 2016). "Identification of the novel synthetic cannabimimetic 8-quinolinyl 4-methyl-3-(1-piperidinylsulfonyl)benzoate (QMPSB) and other designer drugs in herbal incense". Forensic Science International. 260: 40–53. doi:10.1016/j.forsciint.2015.12.001. PMID 26795397.